All lobbying filings

TULIPIFERA STRATEGIES

Lobbying for TREATMENT ADVOCACY CENTER · Advocacy, education, and research related to eliminating barriers to the treatment of SMI.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate · $10,000.00 income · posted Nov 6, 2025

Official filing document

Lobbying activity 1

Health Issues

Medicaid IMD Exclusion. The IMD Exclusion, within Sec. 1905(a) of the Social Security Act, generally excludes federal fund participation for treatment provided in an inpatient psychiatric facility.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.